BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  KaliVir Immunotherapeutics Announces Completion of First Cohort of STEALTH-001 Study Evaluating VET3-TGI in Patients with Advanced Solid Tumors

  May 20, 2025

   · 

  3 min read
• Press Releases

  Tvardi Therapeutics to Participate in Upcoming Investor Conferences

  May 20, 2025

   · 

  1 min read
• Press Releases

  Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

  May 20, 2025

   · 

  4 min read
• Press Releases

  Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment

  May 20, 2025

   · 

  6 min read
• Press Releases

  Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

  May 20, 2025

   · 

  4 min read
• Press Releases

  ZyVersa Therapeutics Highlights Published Study Reinforcing That Microglia-driven Inflammation Is Pivotal in Development of Parkinson’s and Alzheimer’s Diseases

  May 20, 2025

   · 

  6 min read
• Press Releases

  Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake

  May 20, 2025

   · 

  7 min read
• Press Releases

  Precision Announces Promotion of Sofia Baig to President, Precision for Medicine and Appointment of Daisy DeWeese-Gatt, MPH, as President, Clinical Solutions, Precision for Medicine

  May 20, 2025

   · 

  5 min read
• Press Releases

  Instem Announces Acquisition of Strong Tower Solutions, Strengthening its Clinical SCE Solutions

  May 20, 2025

   · 

  3 min read
• Press Releases

  atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression

  May 20, 2025

   · 

  7 min read